Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Mortality risk among hemodialysis (HD) patients may be highest soon after initiation of HD. A period of elevated mortality risk was identified among US incident HD patients, and which patient characteristics predict death during this period and throughout the first year was examined using data from the Dialysis Outcomes and Practice Patterns Study (DOPPS; 1996 through 2004). A retrospective cohort study design was used to identify mortality risk factors. All patient information was collected at enrollment. Life-table analyses and discrete logistic regression were used to identify a period of elevated mortality risk. Cox regression was used to estimate adjusted hazard ratios (HR) measuring associations between patient characteristics and mortality and to examine whether these associations changed during the first year of HD. Among 4802 incident patients, risk for death was elevated during the first 120 d compared with 121 to 365 d (27.5 versus 21.9 deaths per 100 person-years; P = 0.002). Cause-specific mortality rates were higher in the first 120 d than in the subsequent 121 to 365 d for nearly all causes, with the greatest difference being for cardiovascular-related deaths. In addition, 20% of all deaths in the first 120 d occurred subsequent to withdrawal from dialysis. Most covariates were found to have consistent effects during the first year of HD: Older age, catheter vascular access, albumin <3.5, phosphorus <3.5, cancer, and congestive heart failure all were associated with elevated mortality. Pre-ESRD nephrology care was associated with a significantly lower risk for death before 120 d (HR 0.65; 95% confidence interval 0.51 to 0.83) but not in the subsequent 121- to 365-d period (HR 1.03; 95% confidence interval 0.83 to 1.27). This care was related to approximately 50% lower rates of both cardiac deaths and withdrawal from dialysis during the first 120 d. Mortality risk was highest in the first 120 d after HD initiation. Inadequate predialysis nephrology care was strongly associated with mortality during this period, highlighting the potential benefits of contact with a nephrologist at least 1 mo before HD initiation.

[1]  R. Strawderman,et al.  Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  A. Collins,et al.  Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. , 2005, Kidney international.

[3]  F. Alvarez-ude,et al.  Inflammation and malnutrition as predictors of mortality in patients on hemodialysis. , 2002, Journal of nephrology.

[4]  Michèle Kessler,et al.  Impact of nephrology referral on early and midterm outcomes in ESRD: EPidémiologie de l'Insuffisance REnale chronique terminale en Lorraine (EPIREL): results of a 2-year, prospective, community-based study. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  A. Collins,et al.  Hematocrit level and associated mortality in hemodialysis patients. , 1999, Journal of the American Society of Nephrology : JASN.

[6]  G. Eknoyan,et al.  Bone metabolism and disease in chronic kidney disease , 2003 .

[7]  R. Swartz,et al.  Analysis of survival of end-stage renal disease patients. , 1982, Kidney international.

[8]  J. Deddens,et al.  Results of treatment in patients with end-stage renal disease: a multivariate analysis of risk factors and survival in 341 successive patients. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  P. Rowe,et al.  Early deaths on renal replacement therapy: the need for early nephrological referral. , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  G. Chertow,et al.  Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. , 2004, Journal of the American Society of Nephrology : JASN.

[11]  Cheng-Ta Yang,et al.  Early Referral as an Independent Predictor of Clinical Outcome in End‐Stage Renal Disease on Hemodialysis and Continuous Ambulatory Peritoneal Dialysis , 2004, Renal failure.

[12]  P. Fein,et al.  Markers for survival in dialysis: a seven-year prospective study. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  R. Foley,et al.  Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. , 1995, Kidney international.

[14]  J. Gaedeke,et al.  Relaxin: exploring the antifibrotic potential of a pregnancy hormone. , 2005, Kidney international.

[15]  N Levin,et al.  NKF-K/DOQI Clinical Practice Guidelines: Update 2000. Foreword. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  A. Collins,et al.  Does predialysis nephrology care influence patient survival after initiation of dialysis? , 2005, Kidney international.

[17]  C. Pollock,et al.  Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  W. McClellan,et al.  Early death in dialysis patients: risk factors and impact on incidence and mortality rates. , 1996, Journal of the American Society of Nephrology : JASN.

[19]  P. Goldwasser,et al.  Predictors of mortality in hemodialysis patients. , 1993, Journal of the American Society of Nephrology : JASN.

[20]  Francesco Locatelli,et al.  Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  B. Pereira,et al.  Hematocrit Level Associated Mortality in Hemodialysis Patients, by Ma JZ, Ebben J, Xia H, Collins AJ. J Am Soc Nephrol 10:610–619, 1999 , 2000, Seminars in dialysis.

[22]  R. Wolfe,et al.  The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study , 2000 .

[23]  Hirokazu Honda,et al.  Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  G. Biesenbach,et al.  PREDIALYSIS MANAGEMENT AND PREDICTORS FOR EARLY MORTALITY IN UREMIC PATIENTS WHO DIE WITHIN ONE YEAR AFTER INITIATION OF DIALYSIS THERAPY , 2002, Renal failure.

[25]  A. Kausz,et al.  Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. , 1999, Journal of the American Society of Nephrology : JASN.

[26]  I. Khan,et al.  Death during the first 90 days of dialysis: a case control study. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  F. Dekker,et al.  The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  L. Wright Survival in patients with end-stage renal disease. , 1991, American Journal of Kidney Diseases.

[29]  M. Kutner,et al.  The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  M. Budoff,et al.  Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. , 2006, Kidney international.

[31]  J. Fink,et al.  Use of erythropoietin before the initiation of dialysis and its impact on mortality. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  F. Port,et al.  Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. , 2005, Kidney international.

[33]  R. Wolfe,et al.  Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2003, Journal of the American Society of Nephrology : JASN.